Information may raise awareness but removing barriers drives behaviour
In the STEP trials, semaglutide 2.4 mg weekly showed average weight reductions of 1215% of body weight over 68 weeks, whilst in the SCALE trials, liraglutide 3 mg daily typically produced 58% weight loss
All medications are eligible for delivery to all 50 states, with same-day delivery options currently available in nearly 3,000 cities and towns and expanding to nearly 4,500 by the end of 2026
Whether youre walking, driving, or just prefer to hear it aloud, click play below
When choosing between Wegovy and Zepbound for your new weight-loss treatment, its very important that you talk with your doctor about all potential side effects and consider which medication is the safest for you , taking into account your medical history and personal situation
ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, et al